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The first generation of genetically modified crop varieties, currently most widespread in the maize and 
soybean sectors, sought to increase farmer profitability by improving agronomic traits. The next 
generation of biotech research is focusing also on breeding for attributes desired by consumers. 
Although not yet commercially available, a new variety of rice, known as ‘Golden Rice’, has been 
genetically engineered to contain a higher level of vitamin A. Thus in contrast with the current 
commercial applications of biotech crops, this new rice variety aims directly at benefiting consumers 
rather than producers. More specifically, it aims at improving the health of poor people in developing 
countries who rely on rice as their main staple food (or would be if it was cheaper) and whose diet is 
nutrient-deficient. This paper analyses empirically the potential economic effects of such an innovation 
in an environment of heated debates about the risks and benefits of these biotech developments. The 
emergence of genetically modified foods is generating policy reactions that are delaying the 
development and adoption of what promises to be a high-payoff technology, particularly for the 
world’s poor. These policy reactions may lead to trade disputes, in which case the way this GMO issue 
is addressed in the WTO’s dispute settlement body could have profound implications for poor 
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JEL Codes: C68, D58, F13, O3, Q17, Q18 1. Introduction 
 
The use of genetic engineering techniques in agriculture and food production is seen as an exiting and 
valuable development by many people who welcome the improvements in production efficiency that 
they offer to farmers and the enhanced nutritional value that is envisioned to benefit consumers. Others, 
however, are objecting strongly, raising environmental, food safety, and ethical concerns. A majority of 
people in Western Europe, Japan and Australia, for example, want at least to have labels on products 
that contain genetically modified organisms (GMOs), while the most extreme opponents want to see 
genetically modified (GM) crops completely excluded from production and consumption in their 
country. 
 
The emergence of genetically modified foods has generated a variety of policy reactions in different 
countries. The most extreme of these could lead to trade disputes in the World Trade Organization 
(WTO). Regardless of whether developing countries are exporters or importers of agricultural crops, 
they will be affected by the biotech policies adopted in countries with which they trade – especially if 
international trade disputes concerning GMOs emerge. The strong consumer skepticism toward genetic 
engineering in some countries, particularly in Europe, will also define the trading environment in which 
developing countries must compete. China, for example, found its exports of processed foods to the 
United Kingdom being restricted in 2000 because they may have contained traces of GM soybean 
imported by China from the United States. In turn China placed a moratorium both on soybean imports 








The use of genetically modified crop varieties is currently most widespread in the maize and soybean 
sectors. These first-generation GM crops have improved agronomic traits such as resistance to pests 
and diseases, and tolerance of specific chemical herbicides. The development of plants with such 
attributes aims at increasing farmer profitability, typically by reducing input requirements and hence 
costs. Over time, as the adoption of such lower-cost technologies spreads, this outward shift in the 
supply curve would lower the consumer price of food. 
 
A second generation of GM crops is focusing on breeding for attributes desired by consumers. 
Although not yet commercially available, a recent example of such biotech research involves a new 
variety of rice, known as ‘Golden Rice’, which has been genetically engineered to contain a higher 
level of beta-carotene in the endosperm of the grain (Ye et al. 2000; Beyer et al, 2002).
1 In contrast to 
the current commercial applications of biotech crops, this new rice variety aims directly at benefiting 
consumers rather than producers. More specifically, it aims at improving the health of poor people in 
developing countries that rely heavily on rice as their main staple food – or would do if it was cheaper 
(in place of less nutritious staples such as maize and sweet potato). As with the first-generation GM 
technology that focused on reducing producers’ unit costs, the benefits over time will be shared 
between producers and consumers, and hence between adopting and non-adopting countries – or would 
be if countries remain open to international trade in these products. 
 
This paper analyses the prospective impacts of countries adopting Golden Rice technology.  First, a 
brief overview of the current status of genetic engineering in agriculture is given, including a 






hereto. Then the paper elaborates on ways in which the emergence of GMOs is prompting the 
development of national regulations and international agreements that could raise difficulties and 
potentially lead to trade disputes in the WTO. Also considered are labeling schemes, as a means of 
addressing certain consumers’ skepticism and their claim of a ‘right to know’.  The case of Golden 
Rice is then addressed by discussing similarities and differences with biotech varieties of maize and 
soybeans that are currently being produced and traded on commercial terms. Some recent empirical 
simulation results of possible benefits of Golden Rice are then presented and reviewed. The paper 
concludes by drawing out implications of the analysis for the WTO and developing countries.   
 
 
2. Current status of genetic engineering in agriculture
2 
 
Genetic engineering techniques and their applications have developed rapidly since the introduction of 
the first genetically modified plants in the 1980s. In the year 2001 genetically modified crops occupied 
53 million hectares of land – a considerable expansion from 1.7 million hectares in 1996 (James 1997, 
1999, 2000, 2001). Cultivation of transgenic crops has so far been most widespread in the production 
of soybeans and maize, accounting for 63% and 11% of total transgenic crop area in 2001, respectively. 
Cotton and canola (rapeseed) made up much of the rest, with only small areas devoted so far to GM 
linseed, cantalope, papaya, potato, squash, sugarbeet, tobacco and tomato.  
 
                                                                                                                                                                        
1 Beta-carotene does not occur naturally in the endosperm of rice, hence the need for genetic modification (Bouis 2000). 
2 Sections 2 and 3 of this paper draw on the authors’ earlier work in this field. See e.g. Nielsen and Anderson (2001a,b) and 






The United States holds almost three-fourths of the total crop area devoted to genetically modified 
crops. Other major GM-producers are Argentina, Canada and China. Up till now the vast majority of 
global transgenic crops have been grown in industrial countries, but the recent uptake of GM crops has 
been most rapid in developing countries. Of the 11% increase in transgenic crop plantings between 
1999 and 2000, 84% of this was in developing countries. Hence, the proportion of transgenic crops 
grown in developing countries increased from 14% in 1997 to 24% in 2000 (James 2001).                                          
 
Continued expansion in the use of transgenic crops will depend in part on the benefits obtained by 
farmers cultivating transgenic instead of conventional crops relative to the higher cost for transgenic 
seeds. So far the improvements have been not so much in increased yields per hectare of the crops but 
rather by reducing costs of production (OECD 1999). That is, genetic engineering in agriculture has 
mainly been used to modify crops so that they have improved agronomic traits such as tolerance of 
specific chemical herbicides and resistance to pests and diseases (James 2001). The development of 
transgenic plants with enhanced agronomic traits aims at increasing farmer profitability, typically by 
increasing factor productivity.  
 
Genetic modification can also be used to improve the final quality characteristics of a product to the 
benefit of the final consumer, perhaps via the food processing industry or livestock producers. Such 
traits may include enhanced nutritional content, improved durability and better processing 
characteristics. This type of crop will in many cases sell at a higher market price to the extent 
consumers perceive it as a different, better-quality product. Most of these types of modification are still 







One such GM crop – vitamin A enhanced rice, known as Golden Rice – is in an advanced stage of 
being developed for commercial use in China (as well as being worked on at the international Rice 
Research Institute in the Philippines). It has the potential of alleviating vitamin A deficiency problems 
in many developing countries. This could have profound implications in developing countries, 
especially among the poor where Vitamin A Deficiency (VAD) is a major problem. It is estimated that 
up to 0.5 million VA-deficient children go blind every year. VAD also weakens the immune system, 
thereby increasing the incidence and severity of infectious diseases and infant mortality rates. For 
adults, the implications can be serious too, especially for pregnant and lactating women. Nearly 0.6 
million women die from childbirth-related causes each year, many of them from complications which 
could be reduced through better provision of VA (Sommer and West 1996). Needless to say these 
problems are greatest among the poorest households in developing countries (Zimmermann and Qaim 
2002). 
 
Consumer acceptance or rejection 
 
A factor that is at least as important in determining the extent of continued expansion of transgenic 
crop plantings and the development and adoption of new GM varieties is consumer attitudes. Certain 
very strong and vocal consumer groups in developed countries are particularly skeptical about the use 
of GMOs in food production and demand non-GM varieties be kept separate from GM varieties.   
 
The apparent lack of direct consumer benefits from the current generation of GM foods has not helped 
foster consumer confidence in GM foods. Consumer concerns over GMOs relate to ethics, in addition 






argument that genetic engineering is simply an extension of traditional plant breeding. They find it 
immoral to interfere with the genetic structure of species. On food safety, the typical issue raised relates 
to potential allergenic risks such as in the case of Brazil nut traces in GM soybeans. The environmental 
concerns relate to potentially harmful effects on non-target species, pollen drift, and the development of 
resistance. Furthermore, consumers demand a ‘right to know’ about food production methods in 
general, and about the use of genetic engineering in particular. 
 
Segregated GM and non-GM markets 
 
The sharp reaction against genetic engineering by some consumers has already initiated the creation of 
differentiated marketing systems for GM and non-GM maize and soybeans (e.g., in the United States). 
Consumer attitudes will be an important determinant for the profitability and hence the viability of 
markets for non-GM varieties in the longer term. For commercial producers it is a matter of assessing 
the benefits and costs of gaining access to niche markets for non-GM crops relative to the benefits of 
perhaps lower production costs associated with cultivating GM crops. Furthermore, many consumers 
are not only critical of the use of genetic engineering techniques in the production of bulk commodities 
such as soybeans and cereal grains. They are also concerned about GM ingredients in animal feed and 
processed foods. To the extent that consumers are in fact willing to pay the additional costs of having 
these preferences, identity preservation systems will develop so that these demands can also be 
satisfied. 
 
Producers in some countries may benefit from the establishment of segregated agricultural markets for 






products in important markets (be they domestic or foreign), (b) the costs of segregating product 
throughout the supply chain, and (c) the difference in productivity between GM and non-GM 
production. In principle these countries may choose to grow GM crops for (domestic or foreign) 
markets where consumers are indifferent as to GMO content, and to supply GMO-free products to 
markets where consumers are willing to pay a premium for this characteristic. Such a market 
development would be analogous to the niche markets that have developed over recent decades for 
organic foods.  
 
The demand for non-GM varieties could very well expand rapidly. Maize and soybeans are used as 
ingredients in a wide range of processed foods as well as in animal feed products. Hence food 
processing industries and livestock producers need to consider the consequences of their input choices 
both in terms of domestic and foreign demand. The European demand for certified non-GM animal 
feed soared in 2001 after supermarkets agreed to pay a premium to keep their concerned consumers 
happy (Reuters 2001a). The demand for non-GM soy meal, for example, is being satisfied by imports 
from Brazil, which has declared itself a non-GM agricultural producer. After the US, Brazil is the 
world’s second largest producer of soybeans.  
 
Current methods of testing a food product for possible GMO content are not completely reliable. 
Heating genetically modified maize, for example, eliminates the genetically modified proteins. This 
renders current testing methods unsatisfactory if the information demanded by consumers is whether or 
not genetic engineering techniques have been used at any stage in the production process. Therefore, in 
order to provide consumers with the choice of purchasing guaranteed non-GM foods, the principles of 






known from existing specialty markets (e.g. high-oil maize), but are also applied to a greater or lesser 
extent for almost all traded agricultural products. After classification has taken place, the subsequent 
handling, storage and processing systems must ensure that the identity of the product is retained 
throughout the supply chain – as far and as detailed as the final user or the regulatory authorities 
require (see Buckwell et al. (1999) for a more detailed discussion of the economics of IP systems). 
Identity preservation systems to enable reliable labeling of food can be costly, however, and more so 
the more stages of processing or intermediate input use a crop product goes through before final 
consumption. An early European survey suggests full traceability could add 6-17% to the farm gate 
cost of different crops (European Commission 2000), although subsequent analyses indicate that the 
impost is likely to be somewhat lower particularly after the initial setup costs have been met.  
 
 
3. What is the GMO trade debate about? 
 
As the use of genetic engineering moves into its second generation and increasingly provides quality-
enhanced foods (e.g. better nutritional content, improved durability), consumer attitudes toward GMOs 
may change. Nevertheless, as long as environmental and food safety consequences remain uncertain 
there will be some consumers who wish to avoid GMOs altogether. Sheldon (2001) asserts that the 
public concerns voiced in Europe are mainly a popular movement rather than an explicit attempt to 
introduce barriers to trade: consumers feel that they are bearing heavy risks while capturing few 
benefits. Will a successful Golden Rice story carry more weight in the minds of well-to-do European 
consumers? To help answer that question, we consider first the wide array of approaches to national 









The differences in approaches to GMO regulation are most stark between the US and the EU, and they 
have the potential to have a significant impact on trade both between them and with third countries. 
Because of that, trade in agricultural biotech products could easily become a controversial issue within 
the World Trade Organization (WTO). The US might accuse the EU of using this issue as an excuse for 
replacing farm price-support policies, which are being phased down following the Uruguay Round 
Agreement on Agriculture, with technical barriers to trade using consumer concerns as an excuse. 
Reuters quoted the US Agriculture Secretary as having said that it would be difficult for the US to 
accept the EU's recent proposal on labeling of genetically modified foods (based on a tight system of 
tracing and labeling products at every step ‘from farm to fork’) as not trade distorting.
3 The possibility 
of challenging the proposal at the WTO was mentioned explicitly.  
 
The resistance to GMO production and use triggered in October 1998 the imposition of a de facto 
moratorium on the authorization of new releases of GMOs in the European Union (EU), pending 
stricter regulation in this areas. The European Commission has now proposed a very strict approval, 
traceability and labeling policy for GMOs, which is expected to be accepted by all 15 EU member 
states for implementation in late 2002 or in 2003. Hence, the EU is now commencing the tough job of 
trying to get all 15 EU members to agree to lift the three-year moratorium. By contrast, the permit 






genetically modified foods, the United States Food and Drug Administration (FDA) does not 
distinguish between foods produced from genetically modified crops and foods produced from crops 
developed by other technologies. This means that genetically engineered foods and food ingredients 
must meet the same safety standards as other food products (Food and Drug Administration 1995). 
 
There are also marked differences in national labeling requirements. The US Food and Drug 
Administration does not require labeling of GM foods per se, but only if the transgenic food is 
substantially different from its conventional counterpart. The EU, by contrast, requires labeling of all 
foodstuffs, additives and flavors containing 1% or more genetically modified material (Regulations 
1139/98 and 49/2000). Individual countries within the EU have added further requirements (OECD 
2000).  
 
Numerous non-European countries, including some developing countries, have also enacted GMO 
consumer legislation. Japan, Australia and New Zealand have introduced mandatory labeling for all 
foods containing GMOs. Many developing countries also are beginning to develop regulations related 
to genetically engineered products. Operational field-testing regulations have, for example, been 
implemented in Argentina, Brazil, Mexico, Chile, Costa Rica, Cuba, India, the Philippines and 
Thailand.  
 
International trade agreements 
 
                                                                                                                                                                        
3 Reuters (2001b). It is not only the Americans that find the EU proposal costly. The Food Standards Agency of the UK is 






The Cartagena Protocol on Biosafety 
 
Given the different attitudes and national approaches to regulation of genetically modified products, 
future trade disputes are a distinct possibility. The Cartagena Protocol on Biosafety (finalized in 
Montreal on 29 January 2000 as a part of the 1992 Convention on Biological Diversity) may have 
added to that likelihood. The Biosafety Protocol has the objective of ensuring safe transboundary 
movement of living modified organisms resulting from modern biotechnology. If ratified by the 
parliaments of 50 signatories, the Protocol will not only reconfirm the rights of ratifying countries to 
set their own domestic regulations but also allow each country to decide whether and under what 
conditions it will accept imports of GM products for release into the environment (for example, as 
planted seeds). This condoning of import restrictions appears also to apply to GMOs intended as food, 
feed or for processing.
4 Importantly, the Protocol stipulates that lack of scientific evidence regarding 
potential adverse effects of GMOs on biodiversity, taking into account also the risks to human health, 
need not prevent a ratifying country from taking action to restrict the import of such organisms in order 
to reduce perceived risks (UNEP 2000). In essence, this reflects an acceptance of the guiding influence 
of the precautionary principle, that is, “better safe than sorry”.
5 The Protocol requires that GMOs 
intended for intentional introduction into the environment or for contained use must be clearly 
identified as living modified organisms; but modified organisms intended for direct use as food or feed, 
                                                                                                                                                                        
necessarily provide consumers with the information they demand (see Agra Europe, 5 October 2001). 
4 Details concerning the latter products are still to be decided, however, pending the findings of the FAO/WHO Codex 
Alimentarius Commission’s Ad Hoc Intergovernmental Task Force on Foods Derived from Biotechnology. There is 
uncertainty because while the Protocol relates to biosafety rather than human safety, the phrase “… taking into account 
effects on human health …” survived the drafting process. The Codex Task Force was due to report within four years of its 
creation in June 1999, but its progress has been slower than anticipated.  
5 The precautionary principle implies that considerations of human health and the environment rank higher than possible 






or for further processing, just require a label stating that the product “may contain” such organisms. No 
labeling requirements for processed foods such as cooking oil or meal were established by the Protocol.  
 
The WTO agreements and transgenic products 
 
An important aspect of the Biosafety Protocol that is unclear and hence open to various interpretations 
concerns its relationship with the WTO agreements. The text states that the “Protocol shall not be 
interpreted as implying a change in the rights and obligations of a Party under any existing international 
agreements”, but at the same time the Protocol claims that this statement is “not intended to 
subordinate [the] Protocol to other international agreements” (UNEP 2000 p.1). Certainly the 
Protocol’s objective of protecting and ensuring sustainable use of biological diversity whilst also taking 
risks to human health into account is not inconsistent with WTO agreements. The WTO acknowledges 
the need of member states to apply and enforce trade-restricting measures in order to protect human, 
animal or plant health and life as well as public morals. That right for a country to set its own 
environmental and food safety regulations at the national level is provided for in Article XX of the 
GATT.  But the key goal of the WTO is to achieve efficient use of the world’s resources by reducing 
barriers to international trade. For that reason WTO members also have agreed to not use unduly trade-
restrictive measures to achieve environmental or food safety goals. More than that, such measures must 
be consistent with the key principles of the WTO: non-discrimination among member states, ‘national 
treatment’ of imports once having entered the domestic market, and transparent customs procedures. 
Whether the current WTO agreements prove to be in conflict with the rights to restrict trade in living 
modified organisms apparently provided for in the Biosafety Protocol, only time – and possibly legal 







Members of the WTO also have trade obligations under other WTO agreements that restrict the extent 
to which trade measures can be used against GMOs. More specifically related to food safety and 
animal and plant health are the Agreement on Sanitary and Phytosanitary Measures (SPS) and the 
Agreement on Technical Barriers to Trade (TBT). These agreements allow member states to impose 
certain restrictions on trade if the purpose of the measure is to protect human, animal or plant life and 
health. The TBT agreement also covers technical measures aimed at protecting the environment and 
other objectives. At the same time the agreements aim at ensuring that applied measures and technical 
regulations are no more trade-restrictive than necessary to fulfill the stated objectives.        
 
Both the SPS and TBT agreements encourage the use of international standards, guidelines and 
recommendations where they exist, such as in the realms of the Codex Alimentarius (the FAO’s 
international food standards body). Currently there are no international standards for genetically 
modified products,
6 although the Biosafety Protocol explicitly notes that signatories “shall consider the 
need for and modalities of developing standards with regard to the identification, handling, packaging 
and transport practices, in consultation with other relevant international bodies.” (UNEP 2000 p. 10, 
Article 18.3.) International harmonization of regulatory approval procedures for genetically modified 
products is currently under discussion in several forums including the FAO and OECD. The 
establishment of international standards for the production, regulation and labeling of these products 
may be helpful as a way of reducing future trade disputes among developed countries – but could 
impose onerous compliance costs on poorer GM-exporting countries.  
                                                 
6 However, the Codex Committee on Food Labelling is currently considering the adoption of an international standard on 







Under the SPS agreement a country may apply higher than international standards only if these can be 
justified by appropriate scientific risk assessments. In other words, while the SPS agreement explicitly 
allows member states to set their own standards for food safety and animal and plant health, it requires 
that measures be based on scientific risk assessments in a consistent way across commodities. The TBT 
agreement is more flexible because member states can decide that international standards are 
inappropriate for a number of other reasons, such as national security interests (GATT Article XXI). 
Hence it is of key importance to determine by which WTO agreement a given trade measure is covered. 
The SPS agreement covers food safety measures and animal and plant health standards regardless of 
whether or not these are technical requirements. The TBT agreement, on the other hand, covers all 
technical regulations, voluntary standards and compliance procedures, except when these are sanitary 
and phytosanitary measures as defined in the SPS agreement (WTO 1998a).     
 
The SPS agreement’s scientific requirement is important because it is more objective than the TBT 
agreement’s criteria for determining what is a justifiable trade restriction and what is hidden 
protectionism. On the other hand, the SPS agreement may be inadequate for legally justifying 
restrictions introduced on the basis of some vocal groups’ opposition to GM foods. Official disputes 
about trade in genetically modified products have not yet materialized
7, but experience from earlier 
WTO dispute settlement cases comparable to the GMO debate give an indication as to how the existing 
rules may be applied. The SPS agreement was used, for example, in the beef hormone dispute between 
                                                 
7 Thailand did formally object to Egypt’s ban on GM imports in the latter half of 2000, but the matter was settled without 
going to the trouble of setting up a Dispute Settlement panel at the WTO. It objected not to Egypt’s right to impose a ban, 






the US and the EU (WTO 1998). In short, the EU import ban on meat and meat products from 
hormone-fed livestock was found to be in conflict with the EU's WTO obligations, the main argument 
being that the EU could not present documented scientific risk assessment of the alleged health risk to 
justify the ban.  
 
Scientific evidence is not always sufficient for governments to make policy decisions, or it may simply 
be unavailable. In such cases, Article 5.7 of the SPS agreement allows WTO member states to take 
precautionary measures based on available pertinent information. At the same time, members are 
obliged to seek additional information so that a more objective evaluation of the risks related to the 
relevant product or process can be made within a reasonable period of time. The precautionary 
principle is an understandable approach to uncertainties about genetically modified products, but there 
is a risk that when used in connection with internationally traded products, it can be captured by 
import-competing groups seeking protection against any new technology-driven competition from 
abroad. It may thus be extremely difficult to assess whether a measure is there for precautionary 
reasons or simply as a form of hidden protectionism. For this reason, attention will focus acutely on 
how the provisions of the Biosafety Protocol – the most explicit acceptance of the use of the 
precautionary principle in an international trade agreement relating to food products to date – are 
interpreted given current WTO commitments. 
 
The existing trade agreements deal with regulations and standards concerning not just products but also 
production processes and methods if but only if they affect the characteristics or safety of the product 
                                                                                                                                                                        
settlement in early 2003, but postponed that action in the hope of securing France and Germany’s approval in the UN 






itself: Standards for production processes that do not affect the final product are not covered by the 
existing agreements. In relation to genetically engineered products, if the process itself were to alter the 
final product in such a way that there are adverse environmental or health effects associated with 
consumption, use or disposal of the product, restricting trade in this product need not violate existing 
WTO rules, ceteris paribus. However, if genetic engineering only concerns the production process and 
not the final characteristics of a transgenic product, domestic regulations that restrict the use of this 
method of production cannot be used to restrict imports of products produced by this method simply 
because the importing country finds it unacceptable by its own environmental, ethical or other norms.
8  
 
This discussion leads back to the role of scientific evidence. Some would argue that genetically 
modified products are different from conventional products regardless of whether this can be verified 
scientifically in the final product. One of the priorities of the European Commission in the next WTO 
round of multilateral trade negotiations is to obtain a clarification of the role of non-product-related 
processes and production methods within the WTO (European Commission 1999). If trade restrictions 
based on production methods are allowed, this could lead to the inclusion of a long list of non-tariff 
barriers, and not only in relation to biotechnology products. 
    
Labeling of foods in relation to international trade is normally covered by the TBT agreement unless 
the label relates directly to food safety, in which case it is covered by the SPS agreement. Only labeling 
programs that concern production processes affecting the final product would be covered by the 
existing TBT agreement. Determining whether or not a genetic modification affects the final product 
                                                 
8 This product/process distinction became (and has remained) prominent at the WTO as a result of the famous tuna-dolphin 






will probably have to be done on a case-by-case basis. Where labeling programs are not encompassed 
by the TBT agreement, which potentially may be the case for many transgenic products, the other 
agreements of the WTO will be applicable without exceptions (Tietje 1997). GATT Article III 
concerning non-discrimination, for example, stipulates that member states may not discriminate 
between otherwise like goods on the basis of their country of origin. A key issue using this Article will 
be the interpretation of the concept of ‘like goods’ and whether the presence of genetically modified 
material is ‘sufficient’ to differentiate products. Article III seeks to avoid measures that are based on a 
false differentiation of products.  
 
In short, the emergence of GMOs in agricultural and food production introduces several new and 
contentious issues to be dealt with by the WTO membership and ultimately its Dispute Settlement 
Body (DSB). The DSB has not yet been able to resolve the dispute over the EU’s ban on imports of 
beef produced with growth hormones (WTO 1998), so it is difficult to see how it will be able to do any 
better with the far more complex issue of GM products should the EU choose to ban their importation 
too – particularly now that there is a Biosafety Protocol on the table condoning the use of the 
precautionary principle and suggesting scientific evidence need not prevent importing countries from 
restricting GM trade. Mandatory labeling requirements of all GMO-inclusive products including 
processed foods such as the proposal of the European Commission will probably not violate existing 
WTO rules as long as they do not discriminate between foreign and domestic goods. Such requirements 
will add significantly to trade costs, however, and are triggering threats of challenges at the WTO (e.g., 
from the US – see footnote 7 above).  
 
                                                                                                                                                                        






A major international trade dispute concerning GMOs could prove very harmful to agricultural-
exporting countries, in particular those countries that are highly dependent on exporting to Western 
Europe. Even if these countries were fortunate enough to benefit from the new technology in producing 
for their own consumption, they might risk having their products refused at the European borders solely 
because they are genetically modified. A market-based segregation of agricultural production into 
GMO-inclusive and GMO-free varieties, on the other hand, would allow for a broader choice of 
production methods, particularly if GMO-free products carry a price premium. This would, however, 
require the imposition of comprehensive testing, certification and labeling systems that can satisfy the 
requirements of importing countries. Such systems may prove to be very demanding financially and in 
terms of technical expertise, especially for developing countries. Furthermore, for the label to be 




4. Golden Rice in the context of international trade 
 
The above discussion reveals that there are a number of potentially contentious issues relating to trade 
in genetically modified foods. Whether or not these issues develop into actual trade disputes only time 
will tell. However, if they do, there is a risk that the second generation of GM foods, that have the 
potential of benefiting consumers directly, may never materialize. Perhaps the most important of these 







As already mentioned, optimists view Golden Rice as having the potential of improving the lives of 
millions of the poorest people in the world. Judging by the current intake of vitamin A and beta-
carotene, Robertson et al. (2001) assert that Golden Rice could significantly boost total intake, and 
recommend Golden Rice as a vitamin A intervention strategy for Asia especially due to rice’s unique 
position as the main food staple in Asia. Robertson et al. (2001) do, however, mention five unresolved 
issues: (i) it is uncertain how much vitamin A can in fact be delivered through Golden Rice, (ii) 
consumer acceptance is uncertain
9, (iii) success of Golden Rice depends in part on expanding 
nutritional education, (iv) potential food safety concerns need to be resolved, and (v) the costs of 
supplying Golden Rice may be high because there will be higher seed costs as well as costs related to 
keeping Golden Rice production and marketing channels separate from other rice channels. The authors 
conclude that Golden Rice is probably best seen as a supplementary strategy for addressing nutrition 
problems in developing countries. Whether Golden Rice can play even that more limited role depends 
on the extent to which the technology per se gets caught up in the very polarized debate at the 
international level.  
 
What makes Golden Rice different? 
 
To date, the discussion about GMOs in an international trade context has focused on the two main GM 
crops, maize and soybeans, and how trade in these commodities would be affected by policy choices in 
regions hostile to this biotechnology, Western Europe being the strongest opponent. Nielsen and 
Anderson (2001b), for example, examine the consequences of a Western European ban against imports 
                                                 
9 The acceptance of new rice varieties (particularly in Asia) is paramount to their success. Consumer preferences for specific 






of GM commodities and of a more market-oriented policy solution based on labeling. The findings are 
that an import ban would be very costly to the Western European region itself given its relatively 
strong dependence on imports of especially soybeans (but also maize) from regions that are enthusiastic 
adopters of GM varieties.     
 
Nevertheless, several GM varieties are judged as being safe for both the environment and consumers, 
even in Europe. The most recent policy developments therefore point in the direction of choosing 
labeling as the preferred solution, acknowledging that some consumers want to be able to avoid GMOs 
altogether. Nielsen, Thierfelder and Robinson (2001) analyze the consequences of such consumer 
attitudes to GMOs in a framework in which the entire food processing chain – from primary crops 
through livestock feed to processed foods – is segregated into GM and non-GM lines of production 
supported by labeling and traceability schemes. The results from that empirical analysis show that 
increasing consumer aversion toward GMOs will have substantial effects on trade, production and 
prices not only for the crop sectors that benefit directly from the new technology, but also for the 
sectors that use these crops as inputs (for example, in livestock production). 
 
Clearly, the impact that biotech policies and consumer attitudes will have on the production and trade 
of crops that are potentially subject to genetic modification in different countries depends on a number 
of factors. First of all, the ease with which crops are genetically modified varies by crop. To date the 
technique has been successfully applied to maize and soybeans, for example, but the process is 
apparently more complex for wheat. Second, the effect on production and possibly also on trade may 
depend on whether the aim of the modification is to improve the agronomic attributes of the crop or to 






attitudes towards GMOs will depend on how traded the crop in question is and between which 
countries. Finally, the spillover effects on the rest of the economy will depend on whether the crop in 
question is consumed directly, whether it is used primarily as animal feed, or whether it is used mainly 
as an input to the food processing industry. 
 
A number of aspects separate the Golden Rice case from the maize and soybean cases. From a staple 
food perspective rice is of vital importance to many developing countries - particularly those in Asia - 
and only of marginal importance to developed countries. More than 95% of world rice production and 
consumption takes place in developing countries, with 90% produced and consumed in Asia 
(FAOSTAT 2001). By contrast, the US and the EU are two of the major producers and traders of maize 
and soybeans. Judging by the history of international trade disputes to date, the GMO trade debate is 
likely to be confined to the controversies between these two particular WTO members. Nonetheless, 
that debate inevitably will have some spillover effects on developing countries. This is already evident 
in China’s unwillingness to date to contemplate approving the release of GM rice, as it was in its 
decision in 1995 to cease growing GM tobacco because of strong opposition by tobacco imports in the 
US and elsewhere (Huang et al. 2002). More broadly, it is affecting the willingness of the private sector 
and the international donor community to support GMO food research and development. 
 
Another major difference that distinguishes the discussion of Golden Rice in an international trade 
context from the discussion to date is that rice is primarily consumed in the country where it is 
produced, with only a small share of total rice production entering the international market. Over the 
period 1961-99 the average shares of production exported have been 18% for wheat, 14% for maize, 






the introduction of genetically modified rice varieties, be they vitamin-A enhanced Golden Rice, pest-
resistant rice or herbicide-tolerant rice, will be primarily domestic. Even so, there are some countries 
where rice exports make up a substantial part of total sales and where potential trade disputes relating 
to genetic engineering as such could be directly harmful. Rice exports are concentrated in the hands of 
just a few large exporting nations. The six largest rice exporters in 1999 were Thailand, Vietnam, 
China, the USA, India and Pakistan (in that order in volume terms). The importance of rice exports is 
very different for these exporters. For the two largest rice producers - China and India - international 
trade is a residual market (2% and 3% of production, respectively), while for Thailand, Vietnam, 
Pakistan and the US very substantial shares of production are sold on foreign markets (45%, 22%, 35% 
and 45%, respectively, in 1999 (FAOSTAT 2001)).  Hence for the latter countries the choice regarding 
GM versus non-GM varieties will be important, depending on their trading partners. 
 
In the cases of maize and soybean, two of the major traders involved are the United States (mainly as 
an exporter) and the European Union (mainly as an importer). Particularly in the case of soybean, there 
are interests at stake on both sides of the equation. The US soybean producers export a large share of 
their produce, and a substantial part is destined for the EU market. On the import side, the EU is fairly 
dependent on imported soybean products and a substantial part is sourced from the United States. 
Hence potential disputes on this front would be harmful to both traders. In the case of maize, however, 
there is somewhat more space for the EU to increase its own production and/or to source imports from 
non-GMO countries. Likewise, the maize export pattern of the United States is more diverse and so 







In the case of international rice trade, the most important export markets for Thai rice are Indonesia and 
Malaysia. Thailand also exports rice to large African nations such as Nigeria, Senegal and South 
Africa. Thai rice competes with US rice in certain high-quality markets such as the European Union, 
the Middle East and South Africa, and with Vietnam, India, Pakistan and Myanmar in intermediate and 
low-quality markets (Nielsen 2002). Given that Thailand already has experience in exporting premium-
quality specialty rice to high-income markets such as the EU, there is scope for ensuring that this rice is 
non-GM. 
 
For Vietnam, the most important markets are Indonesia, Malaysia and the Philippines. Sales to Iraq, 
Iran and Cuba are also important to Vietnamese rice exports as are former political ties to Eastern 
Europe. None of these current importers seem to be particularly concerned about GM products but, if 
Vietnam is to compete with Thailand in selected higher-income markets in the future, there may be a 
reason for its farmers also to focus on developing non-GM varieties.  
 
Over the past few years, China has been a major rice competitor with Vietnam. China exports mainly to 
Indonesia, the Philippines and Malaysia, just like Vietnam. China also exports to politically sensitive 
countries such as Cuba and Iraq. The country’s communist history is also evident in the rice export 
pattern. In contrast with Vietnam, however, China has managed to gain access to the Japanese market 
after the Uruguay Round Agreement on Agriculture minimum access requirements were put in place in 
1995.  
 
India exports both low-quality milled rice to developing countries such as Bangladesh as well as 






Middle East, the EU and the United States. Russia, South Africa, Sub-Saharan Africa and the Middle 
East are major purchasers of non-basmati rice. Like India, Pakistan exports both high-quality basmati 
rice to high-income markets as well as lower-quality rice to developing countries, mainly in Africa, 
where it competes with Thailand, Vietnam and China. So, just like Thailand, it seems that India and 
Pakistan will fare well if they can manage both GM and non-GM varieties. 
 
A final issue to raise when comparing rice on the one hand, and maize and soybean on the other, is that 
rice is almost exclusively used for human consumption. According to FAOSTAT (2001) only 3% of 
total production is used for animal feed. Also, rice does not get used much in producing other 
processed foods, unlike soybean products.  Maize and soybean are used to a much larger extent as 
animal feed. Hence there will be differences with respect to the spillover effects on other sectors of the 
economy, and on the cost of addressing consumers’ right to know if a product contains GMOs.  
 
Golden Rice may open the door to other GM rice varieties 
 
Since Golden Rice is the first major example of a genetically modified food that aims directly at 
improving consumer nutrition, and more specifically the nutrition of poor people in the world's 
developing countries, a natural question is whether this can pave the way for other GM foods. One 
might anticipate that people in developing countries would adopt a more positive stance toward GMOs 
than people in rich countries precisely because one of the first GM crops they encounter provides them 







The acceptance of Golden Rice might open the door to accepting other useful GM rice varieties. Other 
GM rice varieties aim at addressing agronomic problems such as the control of weeds. Currently rice 
producers use herbicides, crop rotation, flooding and tilling as the main instrument of combating 
weeds. By using herbicide resistant varieties there is scope for using land and water more efficiently 
and thereby reducing the need for these and other inputs. Another useful rice variety is virus-resistant 
rice. In Africa, for example, the yellow mottle virus causes substantial crop losses. In both Asia and 
Africa nematodes cause large yield losses. These pests are often combated using environmentally 
harmful chemicals, and so the development of virus-resistant rice varieties could solve part of this 
problem. Consumer acceptance of such varieties in developing countries will depend, however, on their 
taste, color and cooking properties because, as discussed by e.g. Latham (1998), consumer preferences 
for specific types and qualities of rice are crucial in Asian economies. 
 
 
5. Quantifying the gains from Golden Rice 
 
There are several dimensions to the task of quantifying the economic gains from the adoption of GM 
rice. One is the productivity growth it offers farmers, in terms of fewer inputs being required per unit of 
output. Huang et al. (2002) suggest these could amount to as much as a 7% saving, but to be 
conservative we assume below that primary factor and intermediate input productivity improves by 
5%.
10 Another dimension is the increase in demand that might be expected for Golden Rice because of 
its improved nutritional attribute. That is not modelled here because it requires segregating the world’s 
                                                 
10 Our shock is uniform across all inputs and primary factors. Huang et al. (2002) fine tune that somewhat in their analysis 






rice market into GM-free and GM-inclusive rice.
11 And a third dimension is to quantify the economic 
value of the health benefits that might result from Golden Rice. Results from a recent study o that issue 
are summarized below. 
 
Prospective gains from rice productivity improvement 
 
On the assumption that rice-consuming developing countries are more tolerant of new GM rice 
varieties, what impact would a reduction in the cost of producing rice have on global rice markets? This 
question can be addressed using the same technique as in our earlier analyses of GM maize and 
soybean (Nielsen and Anderson 2001a,b). The analytical framework used is the global, economy-wide 
GTAP (Global Trade Analysis Project) model and database.
12 The country aggregation adopted reflects 
the facts that paddy rice production accounts for up to one-quarter of agricultural production in Asia 
and one-fifth in Sub-Saharan Africa, but is negligible in other regions.  
 
The results in Table 1 show the implications under current policies of introducing genetically modified 
paddy rice which is assumed to increase primary factor and intermediate input productivity by 5%. The 
regions that are assumed to have access to this technology are North America, the Southern Cone 
                                                 
11 Two recent empirical studies that so segregate the markets are Stone at al. (2002) where grains are treated as a group, and 
Jackson and Anderson (2003) where just soybean and maize markets are analysed. 
12 The GTAP model is a multi-regional, static applied general equilibrium model based on neo-classical microeconomic 
theory (Hertel 1997). Markets are characterised by perfect competition, the technology of the profit-maximizing producers 
exhibit constant returns to scale, and substitution between intermediate inputs is possible. The behaviour of the utility-
maximising consumers is captured in a non-homothetic private demand system. Capital and labour are perfectly mobile 
between sectors, whilst the total supply of factors of production is fixed within each region. Land is limited to use in the 
primary agricultural sectors, and shifts among these are determined by transformation elasticities. International trade is 
described by an Armington specification (Armington 1969), which means that products are differentiated by country of 
origin. This enables a specification of the bilateral trade flows rather than simply net trade. Macro closure of the model is 






countries of Latin America, China, South Korea, Taiwan, Southeast Asia, India and the Rest of South 
Asia. (Sub-Saharan Africa is assumed to lack the infrastructure to be among the first adoptors of this 
technology.) In this scenario it is assumed consumers are indifferent between GM-free and GM-
inclusive rice.   
 
That assumed technology boost would cause Chinese and Indian paddy rice production to increase by 
just 0.3% and the Rest of South Asia’s by even less, while the increase is around 2% for North America 
and Southeast Asia even though all regions experience the same assumed productivity increase. These 
differences are partly explained by the structures of intermediate use of paddy rice: 27% of paddy rice 
production in China is used to feed livestock and only about half of paddy rice production is further 
processed, whereas in Southeast Asia paddy rice is not used as livestock feed and almost all is 
processed. Chinese consumers spend an equal share of total food expenditure on processed and 
unprocessed rice, whereas consumers in Southeast Asia almost exclusively purchase processed rice 
while those in South Asia consume mostly unprocessed rice, according to the GTAP database. These 
different degrees of processing mean that the increased productivity in paddy rice production in 
Southeast Asia can result in much higher value-added than an identical increase in paddy rice 
productivity in China or South Asia. Moreover, India and Southeast Asia are major exporters of rice, so 
a foreign market for their increased production exists to the extent that demand for rice is price elastic -
- and the average price of processed rice on world markets declines by about 3%. The domestic price of 
paddy rice within both East and South Asia declines by more -- about 6-7%. As a net exporter of rice, 
non-adopting Sub-Saharan Africa in this scenario has to face a lower export price as a consequence of 
                                                                                                                                                                        
comprehensive description of the structures of the individual economies and the commodity and services trade between 






increased competition from GM-adopting, rice-exporting countries. This leads to a marked decline in 
Sub-Saharan African exports and a rise in the region’s imports of rice.  
 
In terms of economic welfare, the world economy is estimated to be better off by US$6.2 billion per 
year in 1995 dollars because of such a technology shock, assuming it has no external effects (Table 
2).
13 Western Europe gains mostly because resources move out of producing highly protected rice 
there. The only regions in that table to lose are the US and Australia, and their loss is trivial. The 
welfare decomposition reveals that the reason for the loss is that the deterioration in their terms of 
trade, because of the fall in international rice prices, outweighs the gain from productivity growth in 
this crop (due to the minor importance of rice to both countries). All of Asia’s adopting regions gain 
substantially, and Asia’s developing countries as a group capture all but one-sixth of the global gains. 
All gain from the technological improvement by similar amounts, but Southeast Asia gains less overall 
because more resources are attracted to its relatively assisted rice sector. 
 
Clearly, this is another ‘green revolution’ for Asia (and potentially other regions including Sub-Saharan 
Africa should they adopt the technology), even if the gains were to be confined to cost savings for rice 
producers. But if in fact the gains extend also to health benefits for undernourished rice consumers, 
how much would that add to the $6 billion global gain per year reported above? No global studies of 
that are yet available, but a recent country study hints at the orders of magnitude that could be involved. 
 
                                                 
13 If South Asia did not adopt the new GM technology, the global gains would be reduced to $4.5billion p.a. The reason we 
have not used the model to evaluate the effects of introducing Golden Rice is that we have no way of guessing what the 









Prospective gains from improved health for Golden Rice consumers 
 
In an innovative analysis Zimmermann and Qaim (2002) estimate the potential economic value of the 
health benefits of Golden Rice for the Philippines. They do so by estimating the direct savings in health 
costs associated with Vitamin A Deficiency (leaving aside indirect savings such as for families caring 
for a blind family menber). That is done by examining its impact on disability-adjusted life years 
(DALYs), based on Murray and Lopez (1996), and using the World Bank (1994) estimate of each year 
being worth US$1,000 in terms of lost income and the willingness to pay for health services. Impacts 
on children and well as pregnant and lactating women are evaluated, and a pessimistic and an 
optimistic scenario are presented. The aggregate benefit is estimated to range between $23 and $137 
million per year, or between 0.03% and 0.18% of GDP. If that were to be representative of what could 
be achieved in all East and South Asian developing countries, then for the region as a whole those 
health benefits would amount to between $0.8 and $4.5 billion per year. This is a very substantial 
addition to the $5.3 billion gain shown in Table 2 for that region from the assumed productivity gain 
associated with GM rice. 
 
 
                                                                                                                                                                        
varieties is based on the actual savings that have been generated in the cases of GM maize and soybean and the field-trial 






6. Conclusion: implications for the WTO and developing countries   
 
The introduction of Golden Rice would not be without controversy, but for countries choosing to adopt 
they are mainly of a domestic nature if those countries are less than 100% rice self-sufficient. Among 
the issues such countries would need to grapple with are domestic consumer acceptance, evaluation of 
potential environmental and food safety risks, and the establishment of appropriate regulatory 
frameworks to deal with biosafety risks, intellectual property rights, etc.   
 
However, for countries that are or would become net exporters of rice, GM technology may pose 
greater challenges from an international trade perspective. Even though the above empirical simulation 
results suggest such varieties have the potential to bring much-needed welfare gains to developing 
economies, an important issue for a rice-exporting country would be to evaluate the consumer attitudes 
towards GMOs in its export markets and to be well aware of any rice trade policies (e.g. labeling and 
segregation requirements) affecting GM varieties. For developing countries that are dependent on 
exporting to countries where there are clear preferences against GM products (e.g. the European Union 
and Japan), there may be scope for the development of segregated GM and non-GM rice markets. Then 
the main challenge would be to establish completely segregated lines of production and marketing. 
Consumers’ willingness-to-pay for the non-GM characteristic, the costs of segregation, and any 
productivity differences between GM and non-GM varieties would together determine the economic 







A prior challenge for WTO members, however, is to avert a trade dispute of international dimensions 
because the EU and the US, for example, disagree on appropriate approaches to regulating GM trade.
14 
Averting such a dispute is especially important for the world’s rice-based economies, to reduce the risk 
that this could delay the introduction of beneficial GM rice varieties in developing countries. In other 
words, the “gold” of genetically modified rice might be lost in an international trade dispute about 
genetically engineered foods in general. Missing out on the Golden Rice variety would mean a lost 
chance of improving the health of poor people in rice-consuming developing countries. And that in turn 
could mean they miss out on other GM rice varieties being developed and adopted, and hence on a 
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Production          
Paddy rice  1.8 0.3 2.0 0.3 0.1  -11.5 -0.3
Processed rice  -5.2 0.3 2.4 6.8 -3.1  -1.5 -3.7
Domestic prices         
Paddy rice  -5.5 -6.0 -6.7 -7.2 -7.1  -0.9 -0.1
Processed rice  -0.3 -2.7 -4.5 -3.9 -1.8  -0.4 -0.2
Exports
b          
Paddy rice  10.8 33.6 22.5 28.8 31.7  -23.7 -25.9
Processed rice  -10.2 4.1 10.7 6.8 -5.2  -3.9 -11.6
Imports
b          
Paddy rice  -0.9 -0.1 -8.9 -25.5 -22.4  -0.3 22.2
Processed rice  9.2 5.5 -5.4 4.4 -1.6  0.0 8.0
 
a For space reasons, other regions are omitted from this table.
 
b Includes intra-regional trade. 
c GM rice-adopting region. 
 
Source: Authors’ GTAP model results. 
 
 






Decomposition of welfare results,  
contribution of  (US$ million): 
  US$ million  pa
                      Allocative





North America  -30                                    8  -126 76 
Western Europe  295                                284  14 0 
Australia/New Zealand  -38 1 -39 0 
Japan  144 67 82 0 
South Korea+Taiwan
  1321                                112  81 1122 
China  1715                                226  24 1489 
Southeast Asia  804                              -232  -87 1120 
India  1178                                140  -46 1088 
Rest of South Asia  389                                  53  5 328 
Sub-Saharan Africa   21                                    5  15 0 
Other developing and 
transition economies  422                                101  77 241 
WORLD  6220                               765  0 5466 
 
Source: Authors’ GTAP model results.CIES DISCUSSION PAPER SERIES 
 
The CIES Discussion Paper series provides a means of circulating promptly papers of interest to the 
research and policy communities and written by staff and visitors associated with the Centre for 
International Economic Studies (CIES) at the Adelaide University. Its purpose is to stimulate 
discussion of issues of contemporary policy relevance among non-economists as well as economists. 
To that end the papers are non-technical in nature and more widely accessible than papers published 
in specialist academic journals and books. (Prior to April 1999 this was called the CIES Policy 
Discussion Paper series. Since then the former CIES Seminar Paper series has been merged with this 
series.) 
 
Copies of CIES Policy Discussion Papers may be downloaded from our Web site at 
http://www.adelaide.edu.au/cies/ or are available by contacting the Executive Assistant, CIES, 
School of Economics, Adelaide University, SA 5005 AUSTRALIA. Tel: (+61 8) 8303 5672, Fax: (+61 
8) 8223 1460, Email: cies@adelaide.edu.au. Single copies are free on request; the cost to institutions 
is US$5.00 overseas or A$5.50 (incl. GST) in Australia each including postage and handling. 
 
For a full list of CIES publications, visit our Web site at http://www.adelaide.edu.au/cies/ or write, 
email or fax to the above address for our List of Publications by CIES Researchers, 1989 to 1999 plus 
updates. 
 
0322 Chantal Pohl Nielsen and Kym Anderson “Golden Rice and the Looming GMO Trade 
Debate: Implication for the Poor”, July 2003. 
0321 Anderson, Kym “How Can Agricultural Trade Reform Reduce Poverty?” July 2003. 
0320 Damania, Richard and Erwin Bulte “Resources for Sale: Corruption, Democracy and 
the Natural Resource Curse”, July 2003. 
0319 Anderson, Kym “Agriculture and Agricultural Policies in China and India Post-Uruguay 
Round”, July 2003. 
0318 Bentick, Brian L. and Mervyn K Lewis, “Real Estate Speculation as a Source of 
Banking and Currency Instability: Lessons from the Asian Crisis”, July 2003. 
0317 Barreto, Raul A. and Kaori Kobayashi, “Open Economy Schumpeterian Growth”, May 
2003 
0316 Barreto, Raul A. and Kaori Kobayashi, “Economic Integration and Endogenous Growth 
Revisited: Pro-competitive Gains from Trade in Goods and the Long Run Benefits to 
the Exchange of Ideas”, May 2003. 
0315 Wilson, Patrick J. and Ralf Zurbruegg, “Trends and Spectral Response:  An 
Examination of the US Realty Market”, May 2003. 
0314 Esho, Neil and Anatoly Kirievsky, Damian Ward and Ralf Zurbruegg, “Law and the 
Demand for Property-Casualty Insurance Consumption”, May 2003. (Forthcoming in 
Journal of Risk and Insurance, 2003). 
0313 Wilson, Patrick J. and Ralf Zurbruegg, “Does it Pay to Diversify Real Estate Assets? - 
A Literary Perspective”, May 2003. 
0312 Rajan, Ramkishen, “Taxing International Currency Flows: A Financial Safeguard or 
Financial Bonanza?”, April 2003. 
0311 Rajan, Ramkishen, “Financial Crisis, Capital Outflows and Policy Responses: Simple 
Analytics and Examples from East Asia”, April 2003. 
0310 Cavoli, Tony and Ramkishen Rajan, “Exchange Rate Arrangements for East Asia 






0309 Cavoli, Tony and Ramkishen Rajan, “Designing Appropriate Exchange Rate Regimes 
for East Asia: Inflation Targeting and Monetary Policy Rules”, April 2003. 
0308 Allsopp, Louise, “Speculative Behaviour, Debt Default and Contagion: An Explanation 
of the Latin American Crisis 2001-2002”, March 2003. 
0307 Barreto, Raul. A., A Model of State Infrastructure with Decentralized Public Agents: 
Theory and Evidence, March 2003. 
0306 Pardey, Philip G., Julian M. Alston, Connie Chan-Kang, Eduardo C. Magalhães, and 
Stephen A. Vosti, “Assessing and Attributing the Benefits from Varietal Improvement 
Research: Evidence from Embrapa, Brazil”, March 2003. 
0305 Allsopp, Louise, “Venezuela: A Nation In Need of Reform”, March 2003. 
0304 Allsopp, Louise and Ralf Zurbruegg, “Purchasing Power Parity in East Asia: Why all 
the Fuss?”, March 2003. 
0303 Allsopp, Louise and Ralf Zurbruegg, “Purchasing Power Parity and the Impact of the 
East Asian Currency Crisis”, March 2003. 
0302 Siregar, Reza and Ramkishen Rajan, “Exchange Rate Policy and Foreign Exchange 
Reserves Management in Indonesia in the Context of East Asian Monetary 
Regionalism”, March 2003. 
0301 Jackson, Lee Ann, “Protectionist Harmonization of Food Safety Policies in the Asia-
Pacific Region”, January 2003. 
0236 Damania, Richard, “Protectionist Lobbying and Strategic Investment”, November 2002 
0235 Damania, Richard and John Hatch, “Protecting Eden: Markets or Government?”, 
November 2002. 
0234 Anderson, Kym, “Agricultural Trade Reform and Poverty Reduction in Developing 
Countries”, November 2002. 
0233 Wood, Danielle and Kym Anderson, “What Determines the Future Value of an Icon 
Wine? Evidence from Australia”, November 2002. 
0232 Kym Anderson and Nielsen, Chantal, “Economic Effects of Agricultural Biotechnology 
Research in the Presence of Price-distorting Policies”. November 2002. 
0231 Jackson, Lee Ann, “Who Benefits from Quality Labelling? Segregation Costs, 
International Trade and Producer Outcomes”. November 2002. 
0230 Rajan, Ramkishen and Graham Bird, “Trade Liberalization and Poverty: Where Do We 
Stand?”, November 2002. 
0229 Rajaguru, Gulasekaran and Reza Siregar, “Sources of Variations Between the 
Inflation Rates of Korea, Thailand and Indonesia During the Post-1997 Crisis”, 
November 2002. 
0228 Barbier, Edward B, “Water and Economic Growth”, October 2002. 
0227 Barbier, Edward B, “The Role of Natural Resources in Economic Development”, 
October 2002. (The 49
th Joseph Fisher Lecture.) 
0226 Rajan, Ramkishen and Rahul Sen, “Liberalisation of Financial Services in Southeast 
Asia under the ASEAN Framework Agreement on Services (AFAS)”, October 2002. 
(Forthcoming in Journal of International Banking Law).  
 
 
 